Requirement of the MADS-box transcription factor MEF2C for vascular development

Development

Volumn 125, Issue 22, 1998, Pages 4565-4574

  Lin, Qing ^a   Lu, Jianrong ^a   Yanagisawa, Hiromi ^a   Webb, Robert ^a   Lyons, Gary E ^b   Richardson, James A ^a   Olson, Eric N ^a  

^a UNIVERSITY OF TEXAS AT DALLAS   (United States)

^b UNIVERSITY OF WISCONSIN SCHOOL OF MEDICINE AND PUBLIC HEALTH   (United States)

Author keywords

MADS box; MEF2C; Mouse; Transcription factor; Vascular defect

Indexed keywords

TRANSCRIPTION FACTOR;

ANGIOGENESIS; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CELL DIFFERENTIATION; CONTROLLED STUDY; EMBRYO; EMBRYO DEVELOPMENT; ENDOTHELIUM CELL; GENE DELETION; LETHAL MUTANT; MOUSE; NONHUMAN; PRIORITY JOURNAL; SMOOTH MUSCLE FIBER;

ANIMALS; BLOOD VESSELS; CARDIOVASCULAR SYSTEM; CELL COMMUNICATION; CELL DIFFERENTIATION; ENDOTHELIUM, VASCULAR; GENES, LETHAL; GROWTH SUBSTANCES; HEART; MESODERM; MICE; MICE, MUTANT STRAINS; MUSCLE, SMOOTH, VASCULAR; MYOGENIC REGULATORY FACTORS; RECEPTORS, GROWTH FACTOR; TRANSCRIPTION FACTORS; YOLK SAC;

ANIMALIA; MAMMALIA;

EID: 0031675951     PISSN: 09501991     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (68)

1. Baldwin, H. S., Shen, H. M. and Yan, H. C. (1994). Platelet endothelial cell adhesion molecule-1 (PECAM-1CD31): alternatively spliced, functionally distinct isoforms expressed during mammalian cardiovascular development. Development 120, 2539-2553.
2. Baldwin, H. S. (1995). Early embryonic vascular development. Cardiovascular Research 31, E34-E45.
3. Baldwin, H. S. (1997). Cell adhesion molecules in cardiac endothelial cell development. In Genetic Control of Heart Development (ed. R. P. Harvey, E. N. Olson, R. A. Schulz, and J. S. Altman) pp. 131-140 Human Frontier Science Program, Strasbourg.
4. Bergwerff, M., Verberne, M. E., DeRuiter, M. C., Poelmann, R. E. and Gittenberger-de Groot, A. C. ( 1998). Neural crest cell contribution to the developing circulatory system. Implications for vascular morphology? Circ. Res. 82, 221-231.
5. Black, B. L. and Olson, E. N. (1998). Transcriptional control of muscle development by myocyte enhancer factor-2 (MEF2) proteins. Ann. Rev. Cell Dev. Biol. 14, 167-196.
6. Bour, B. A., O'Brien, M. A., Lockwood, W. L., Goldstein, E. S., Bodmer, R., Taghert, P. H., Abmayr, S. M. and Nguyen, H. T. (1995). Drosophila MEF2, a transcription factor that is essential for myogenesis. Genes Dev. 9, 730-741.
7. Breir, G. and Risau, W. (1996). The role of vascular endothelial growth factor in blood vessel formation. Cell Biol. 6, 454-456.
8. Carmeliet, P., Ferreria, V., Breier, G., Pollefeyt, S., Kieckens, L., Gertsenstein, M., Fahrig, M., Vandenhoeck, A., Harpal, K., Eberhardt, C., Declercq, C., Pawling, J., Moons, L., Collen, D., Risau, W. and Nagy, A. (1996a). Abnormal blood vessel development and lethality in embryos lacking a single VEGF allele. Nature 380, 435-439.
9. Carmeliet, P., Mackman, N., Moons, L., Luther, T., Gressens, P., Can Vlaenderen, I., Demunck, H., Kasper, M. Breier, G., Evrard, P., Muller, M., Risau, W., Edgington, T. and Collen, D. (1996b). Role of tissue factor in embryonic blood vessel development. Nature 383, 73-75.
10. Cheng, T. C., Wallace, M. C., Merlie, J. P. and Olson, E. N. (1993). Separable regulatory elements governing myogenin transcription during mouse embryogenesis. Science 261, 215-218.
11. Coso, O. A., Montaner, S., Framm, C., Lacal, J. C., Prywes, R., Teramoto, H. and Gutkind, J. S. (1997). Signaling from G-protein-coupled receptors to the c-jun promoter involves the MEF2 transcription factor. Evidence for a novel c-jun amino-terminal kinase-independem pathway. J. Biol. Client. 272, 20691-20691.
12. Cserjesi, P., Brown, D., Lyons, G. E. and Olson, E. N. (1995). Expression of the novel basic helix-loop-helix gene eHAND in neural crest derivatives and extraembryonic membranes during mouse embryogenesis. Dev. Biol. 170, 664-678.
13. D'Angelo, G., Struman, I., Martial, J. and Weiner, R. I. (1995). Activation of mitogen-aetivated protein kinases by vascular endothelial growth factor and basic fibroblast growth factor in capillary endothelial cells is inhibited by the antiangiogenic factor 16-kDa N-terminal fragment of prolactin. Proc. Natl. Acad. Sci. USA 92, 6374-6378.
14. Davis, S., Aldrich, T. H., Jones, P. F., Acheson, A., Compton, D. L., Jain, V., Ryan, T. E., Bruno, J., Radziejewski, C., Maison-Pierre, P. C. and Yancopoulos, G. D. (1996). Isolation of angiopoietin-1, a ligand for the TIE2 receptor, by secretion-trap expression cloning. Cell 87, 1161-1169.
15. Dickson, M. C., Martin, J. S., Cousins, F. M., Kulkarni, A. B., Karlsson, S. and Akhurst, R. J. (1995). Defective haematopoiesis and vasculogenesis in transforming growth factor-beta 1 knockout mice. Development 121, 1845-1854.
16. Dumont, D. J., Yamaguchi, T. P., Conlon, R. A., Rossant, J. and Breitman, M. L. (1992). Tek, a novel tyrosine kinase gene located on mouse chromosome 4, is expressed in endothelial cells and their presumptive precursors. Oncogene 7, 1471-1480.
17. Dumont, D. J., Gradwohl, G., Fong, G. H., Puri, M. C., Gertsenstein, M., Auerbach, A. and Breitman, M. L. (1994). Dominant-negative and targeted null mutations in the endothelial receptor tyrosine kinase, tek, reveal a critical role in vasculogenesis of the embryo. Genes Dev. 8, 1897-1909.
18. Edmondson, D. G., Lyons, G. E., Martin, J. F. and Olson, E. N. (1994). MEF2 gene expression marks the cardiac and skeletal muscle lineages during mouse embryogenesis. Development 120, 1251-1263.
19. Ferrara, N., Carver-Moore, K., Chen, H., Dowd, M., Lu, L., O'Shea, K. S., Powell-Braxton, L., Hillan, K. J. and Moore, M. W. (1996). Heterozygous embryonic lethality induced by targeted inactivation of the VEGF gene. Nature 380, 439-442.
20. Firulli, A. B., McFadden, D. G., Lin, Q., Srivastava, D. and Olson, E. N. (1998). Heart and extra-embryonic mesodermal defects in mouse embryos lacking the bHLH transcription factor Hand1. Nature Gen. 18, 266-270.
21. Firulli, A. B., Miano, J. M., Bi, W., Johnson, D., Olson, E. N., Casscells, W. and Schwarz, J. (1996). Myocyte enhancer binding factor-2 expression and activity in vascular smooth muscle cells: association with the activated phenotype. Circ. Res. 78, 196-204.
22. Fishman, M. C. and Chien, K. R. (1997). Fashioning the vertebrate heart: earliest embryonic decisions. Development 124, 2099-2117.
23. Folkman, J. and D'Amore, P. A. (1996). Blood vessel formation: what is its molecular basis? Cell 87, 1153-1155.
24. Fong, G. H., Rossant, J., Gertsenstein, M. and Breitman, M. L. (1995). Role of the Flt-1 receptor tyrosine kinase in regulating the assembly of vascular endothelium. Nature 376, 66-69.
25. Frohman, M. A., Boyle, M. and Martin, G. R. (1990). Isolation of the mouse Hox-2. 9 gene: analysis of embryonic expression suggests that positional information along the anterior-posterior axis is specified by mesoderm. Development 110, 589-607.
26. Gassmann, M., Casagranda, F., Orioli, D., Simon, H., Lai, C., Klein, R. and Lemke, G. (1995). Aberrant neural and cardiac development in mice lacking ErbB4 neuregulin receptor. Nature 378, 390-394.
27. Han, T. H. and Prywes, R. (1995). Regulatory role of MEF2D in serum induction of the c-jun promoter. Mol. Cell. Biol. 15, 2907-2915.
28. Han, J., Jiang, Y., Li, Z., Kravchenko, V. V. and Ulevitch, R. J. (1997). Activation of the transcription factor MEF2C by the MAP kinase p38 in inflammation. Nature 38, 296-299.
29. 2 homeostasis by hypoxia-inducible factor I. Genes Dev. 12, 149-162.
30. Kato, Y., Kravchenko, V. V., Tapping, R. I., Han, J., Ulevitch, R. J. and Lee, J. D. (1997). BMK1/ERK5 regulates serum-induced early gene expression through transcription factor MEF2C. EMBO J. 16, 7054-7066.
31. Kaushal, S., Schneider, J. W., Nadal-Ginard, B. and Mahdavi, V. I. (1994). Activation of the myogenic lineage by MEF2A, a factor that induces and cooperates with MyoD. Science 266, 1236-1240.
32. Kim, S., Ip, H. S., Lu, M. M., Clendenin, C. and Parmacek, M. S. (1997). A serum response factor-dependent transcriptional regulatory program identities distinct smooth muscle cell sublineages. Mol. Cell Biol. 17, 2266-2278.
33. Kirby, M. L. and Waldo, K. L. (1995). Neural crest and cardiovascular patterning. Circ. Res. 77, 211-215.
34. Kozak, K. R., Abbott, B. and Hankinson, O. (1997). ARNT-deficient mice and placental differentiation. Dev. Biol. 191, 1-9.
35. Kuo, C. T., Veselits, M. L., Barton, K. P., Lu, M. M., Clendenin, C. and Leiden, J. M. (1947). The LKLF transcription factor is required for normal tunica media formation and blood vessel stabilization during murine embryogenesis. Genes Dev. 11, 2996-3006.
36. Lee, K., Simon, H., Chen, H., Bates, B., Hung, M. and Hauser, C. (1995). Requirement for neuregulin receptor erbB2 in neural and cardiac development. Nature 378, 394-398.
37. Leveen, P., Pekny, S., Gebre-Medhin, B., Swolin, B., Larsson, E. and Betsholtz, C. (1994). Mice deficient for PDGF B show renal. cardiovascular, and hematological abnormalitites. Genes Dev. 8, 1875-1887.
38. Li, L., Miano, J. M., Cserjesi, P. and Olson, E. N. (1996a). SM22, a marker of adult smooth muscle, is expressed in multiple myogenic lineages during embryogenesis. Cir. Res. 78, 188-195.
39. Li, L., Miano, J. M., Mercer, B. and Olson, E. N. (1996b). Expression of the SM22 promoter in transgenic mice provides evidence for distinct transcriptional regulatory programs in vascular and visceral smooth muscle cells. J. Cell Biol. 132, 849-859.
40. Li, L., Liu, Z-C., Mercer, B., Overbeek, P. and Olson, E. N. (1997). Distinct serum response factor-mediated regulatory networks governing SM22 transcription in smooth, skeletal and cardiac muscle cells. Dev. Biol. 187, 311-321.
41. Lilly, B., Zhao, B., Ranganayakulu, G., Paterson, B. M., Schulz, R. A. and Olson, E. N. (1995). Requirement of MADS domain transcription factor DMEF2 for muscle formation in Drosophila. Science 267, 688-693.
42. Lin, Q., Schwarz, J., Buchana, C. and Olson, E. N. (1997). Control of cardiac morphogenesis and myogenesis by the myogenic transcription factor MEF2C. Science 276, 1404-1407.
43. Lyons, G. E., Micales, B. K., Schwarz, J., Martin, J. F. and Olson, E. N. (1995). Expression of mef2 genes in the mouse central nervous system suggests a role in neuronal maturation. J. Neurosci. 15, 5727-5738.
44. Maison-Pierre, P. C., Suri, C., Jones, P. F., Bartunkova, S., Wiegand, S. J., Radziejewski, C., Compton, D., McClain, J., Aldrich, T. H., Papadopouos, N., Daly, T. J., Davis, S., Sato, T. N. and Yancopoulus, G. D. (1997). Angiopoietin-2, a natural antagonist for tie2 that disrupts in vivo angiogenesis. Science 277, 55-60.
45. Maltepe, E., Schmidt, J. V., Baunoch, D., Brad field, C. A. and Simon, M. C. (1997). Abnormal angiogenesis and response to glucose and oxygen deprivation in mice lacking the protein ARNT. Nature 386, 403-407.
46. Meyer, D. and Birchmeier, C. (1995). Multiple essential functions of neuregulin in development. Nature 378, 386-390.
47. Molkentin, J. D., Black, B. L., Martin, J. F. and Olson, E. N. (1995). Cooperative activation of muscle gene expression by MEF2 and myogenic bHLH proteins. Cell 83, 1125-1136.
48. Molkentin, J., Firulli, A., Black, B., Lyons, G., Edmondson, D., Hustad, C. M., Copeland, N., Jenkins, N. and Olson, E. N. (1996). MEF2B is a potent transactivator expressed in early myogenic lineages. Mol. Cell. Biol. 16, 3814-3824.
49. Molkentin, J. and Olson, E. N. (1996). Combinatorial control of muscle development by basic-helix-loop-helix and MADS-box transcription factors. Proc. Natl. Acad. Sci. USA 93, 9366-9373.
50. Oshima, M., Oshima, H. and Taketo, M. M. (1996). TGF-β receptor type II deficiency results in detects of yolk sac hematopoiesis and vasculogenesis. Dev. Biol. 179, 297-302.
51. Owens, G. K. (1995). Regulation of differential ion of vascular smooth muscle cells. Physiol Rev. 75, 4S7-517.
52. Partanen, J., Armstrong, E., Makela, T. P., Korhonen, J., Sandberg, M., Renkonen, R., Knuutila, S., Huebner, K. and Alitalo, K. (1992). A novel endothelial cell surface receptor tyrosine kinase with extracellular epidermal growth factor homology domains. Mol. Cell. Biol. 12, 1698-1707.
53. Ranganayakulu, G., Zhao, B., Dokidis, A., Molkentin, J. D. Olson, E. N. and Schulz, R. A. (1995). A series of mutations in the D-MEF2 transcription factor reveals multiple functions in larval and adult myogenesis in Drosophila. Dev. Biol. 171, 169-181.
54. Risau, W. (1991). In The Development of the Vascular System (ed. R. N. Feinberg, G. K. Shere and R. Auerbach) pp. 58-68, Karger, Basel.
55. Risau, W. (1995). Differentiation of endothelium. FASEB J. 9, 926-933.
56. Sato, T. N., Qin, Y., Kozak, C. A. and Audus, K. L. (1993). Tie-1 and tie-2 define another class of putative receptor tyrosine kinase genes expressed in early embryonic vascular system. Proc. Natl. Acad. Sci. USA 90, 9355-9358.
57. Sato, T. N., Tozawa, Y., Deutsch, U., Wolburg-Buchholz, K., Fujiwara, Y., Gendron-Maguire, M., Gridley, T., Wolburg, H., Risau, W. and Qin, Y. (1995). Distinct roles of the receptor tyrosine kinases Tie-1 and Tie-2 in blood vessel formation. Nature 376, 70-74.
58. Shalaby, F., Rossant, J., Yamaguchi, T. P., Gertsenstein, M., Wu, X. F., Breitman, M. L. and Smith, A. C. (1995). Failure of blood-island formation and vasculogenesis in Flk-1-deficient mice. Nature 376, 62-66.
59. Shalaby, F., Ho, J., Stanford, W. L., Fisher, K. D., Schuh, A. C., Schwartz, L., Bernstein, A. and Rossant, J. (1997). A requirement for Flk1 in primitive and definitive hematopoiesis and vasculogenesis. Cell 89, 981-990.
60. Srivastava, D., Cserjesi, P. and Olson, E. N. (1995). A subclass of bHLH proteins required for cardiac morphogenesis. Science 270, 1995-1999.
61. Srivastava, D., Thomas, T., Lin, Q., Kirby, M., Brown, D. and Olson, E. N. (1997). Regulation of cardiac mesodermal and neural crest development by the bHLH transcription factor, dHAND. Nature Gen. 16, 154-160.
62. Subramanian, S. V. and Nadal-Ginard, B. (1996). Early expression of the different isoforms of the myocyte enhancer factor-2 (MEF2) protein in myogenic as well as non-myogenic cell linages during mouse embryogenesis. Mech. Dev. 57, 103-112.
63. Suri, C., Jones, P. F., Patan, S., Bartunkova, S., Maisonpierre, P. C., Davis, S., Sato, T. N. and Yancopoulos, G. D. (1996). Requisite role of angiopoietin-1, a ligand for the TIE2 receptor, during embryonic angiogenesis. Cell 87, 1171-1180.
64. Suzuki, E., Guo, K., Kolman, M., Yu, Y. T. and Walsh, K. (1995). Serum induction of MEF2/RSRF expression in vascular myocytes is mediated at the level of translation. Mol Cell. Biol. 15, 3415-3423.
65. Ticho, B. S., Stainier, D. Y., Fishman, M. C. and Breitbart, R. E. (1996). Three zebrafish MEF2 genes delineate somitic and cardiac muscle development in wild-type and mutant embryos. Mech. Dev. 59, 205-18.
66. Toomey, J. R., Kratzer, K. E., Lasey, N. M. and Broze, G. J. (1997). Effect of tissue factor deficiency on mouse and tumor development. Proc. Natl. Acad. Sci. USA 94, 6922-6926.
67. Wilkinson, D. G., Bailes, J. A., Champion, J. E. and McMahon, A. P. (1987). A molecular analysis of mouse development from 8 to 10 days post coitum detects changes only in embryonic globin expression. Development 99, 493-500.
68. Yee, S. P. and Rigby, P. W. J. (1993). The regulation of myogenin gene expression during embryonic development of the mouse. Genes Dev. 7, 1277-1289.